Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia

NCT06670872 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06670872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06670872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 31, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acinetobacter baumannii, pneumonitis